The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has announced a 12-month extension to its substantial reform of the Medical Device Regulations, which will now come into force by July 2024.
Last year, our colleague Dr Zubair Hussain, Chairman of LE4D Global Regulatory and a PharmaMedic partner, provided an insightful strategic update on critical regulatory trends at PharmaMedic's inaugural virtual breakfast briefing. In this new article, we sat down with Dr Hussain once again to learn his latest insights on the three key issues he tips for the top of the regulatory agenda over the coming months. Read on to find out more.
Many thanks to LBIC and Lucy Garnsworthy for featuring PharmaMedic’s insights on recent UK government initiatives to support pharma and medicaldevices regulatory innovation in its winter newsletter. The article features on page 6 of the newsletter.
We enjoyed a very engaging session for our latest virtual breakfast briefing examining the UK's role in the international life sciences community from innovation and regulatory perspectives. If you missed the event, or would like to recap the key takeaways, read our summary, and catch up with the recording here.
With the government, the MHRA has launched a new consultation to shape a new era of medical device regulation in the UK. The objective is to create a framework that improves patient and public safety, increases transparency in regulatory decision-making, and aligns with global best practices. In this article, we summarise the issues and the scope of the potential changes.
